Oral Fecal Microbiota Transplant Feasibility Study in Alzheimer's Disease (AMBITION)
Sponsor: University of Wisconsin, Madison
Terminated
SARS-CoV-2 has been detected in fecal material. Although FMT is screened for SARS-CoV-2, the team decided to end the study to minimize risk to participants.
Other terminated trials from University of Wisconsin, Madison
Other Alzheimer Disease trials with similar outcome
Listed as NCT03998423, this PHASE1 trial focuses on Alzheimer Disease and remains terminated or withdrawn. Sponsored by University of Wisconsin, Madison, it has been updated 13 times since 2019, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
13 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE1
-
Dec 2021 — Jul 2024 [monthly]
Terminated PHASE1
-
Jan 2021 — Dec 2021 [monthly]
Terminated PHASE1
-
Nov 2020 — Jan 2021 [monthly]
Terminated PHASE1
▶ Show 8 earlier versions
-
Aug 2020 — Nov 2020 [monthly]
Terminated PHASE1
Status: Suspended → Terminated
-
Apr 2020 — Aug 2020 [monthly]
Suspended PHASE1
Status: Recruiting → Suspended
-
Jan 2020 — Apr 2020 [monthly]
Recruiting PHASE1
-
Dec 2019 — Jan 2020 [monthly]
Recruiting PHASE1
-
Nov 2019 — Dec 2019 [monthly]
Recruiting PHASE1
-
Sep 2019 — Nov 2019 [monthly]
Recruiting PHASE1
-
Aug 2019 — Sep 2019 [monthly]
Recruiting PHASE1
-
Jul 2019 — Aug 2019 [monthly]
Recruiting PHASE1
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- University of Wisconsin, Madison
- Wisconsin Partnership Program
For direct contact, visit the study record on ClinicalTrials.gov .